Detecting patients with Alzheimer's disease suitable for drug treatment: comparison of three methods of assessment.
BACKGROUND: Therapy to enhance cholinergic function in the brain is under evaluation for the treatment of Alzheimer's disease. Tetrahydroaminoacridine (tacrine) has recently received a product licence in the United States of America for the treatment of Alzheimer's disease, and the licence...
Main Authors: | Wilcock, G, Ashworth, D, Langfield, J, Smith, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1994
|
Similar Items
-
DETECTING PATIENTS WITH ALZHEIMERS-DISEASE
by: Langfield, J, et al.
Published: (1994) -
Drug treatment of Alzheimer's disease - a clinician's view point
by: Wilcock, G
Published: (1991) -
Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000) -
Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994) -
Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)